Suven Life Sciences share news, announcements and annual reports
NSE: SUVENBSE: 530239Healthcare ServicesSmall Cap
Suven Life Sciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995 on BSE, Oct 2003 on NSE
Last close ₹258.85down ₹5.35 (2.03%)BSE ₹258.10
Share price at the NSE close on 30 Oct 2026. Previous close ₹264.20.
30 Oct: open ₹263.50, high ₹265.65, low ₹257.00
52-week range of traded prices to 30 Oct 2026
₹124.11Low, 24 Mar 2026₹403.35High, 1 Sep 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,314 Cr806th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −100.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −63.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,27,67850.0% delivered
Suven Life Sciences dividends
17 filed, newest first.
Feb 2019
5 Feb · Dividend
Jan 2018
30 Jan · Dividend
Feb 2017
Mar 2016
7 Mar · Dividend
May 2015
26 May · Dividend
Board of Directors at its meeting held on May 26, 2015, has proposed a Dividend of Re. 0.60 per share (60% of face value Rs. 1.00 each) for the financial year 2014-15.
May 2014
22 May · Dividend
Board of Directors of the company at its meeting held on May 22, 2014 has recommended dividend Re.0.50 paisa per share(50% of face value Rs.1.00 each) with an additional Special Silver Jubilee year dividend of Rs.2.00 per share (200% of face value of Rs.1.00 each), aggregating to Rs.2.50 per share for the financial year 2013-14,
May 2013
14 May · Dividend
Board of Directors of the company at its meeting held on May 14, 2013 has recommended dividend Re.0.30 paisa per equity share of face value of Re.1/- each (30%) for the financial year ended March 31, 2013.
Aug 2012
14 Aug · Dividend
Board of Directors of the Company in its meeting held on August 14, 2012, has recommended dividend Re. 0.30 paise per equity share of face value of Re. 1/- each (30%) for the financial year ended March 31, 2012 the dividend will be paid on and from October 12, 2012, subject to the approval of Members in ensuing Annual General Meeting.
May 2011
31 May · Dividend
Board of Directors of the Company at its meeting held on May 30, 2011, inter alia, has recommended dividend Re. 0.25 paisa per equity share of face value of Re. 1/- each (25%) for the financial year ended March 31, 2011 the dividend will be paid on and from August 28, 2011, subject to the approval of Members in ensuing Annual General Meeting.
Apr 2010
30 Apr · Dividend
Board of Directors in its meeting held on April 30, 2010, has recommended Dividend of Re 0.25 paise per equity share of face value of Re 1/- each (25%) for the financial year ended March 31, 2010, subject to the approval of Members in ensuing Annual General Meeting.30 Apr · Dividend
Board of Directors of the Company at its meeting held on April 30, 2010 has recommended Dividend Rs.0.25 paise per equity share of face value of Re 1/- each (25%) for the financial year ended March 31, 2010, subject to the approval of members in ensuing Annual General Meeting.
Jul 2009
28 Jul · Dividend
Board of Directors in its meeting held on July 28, 2009, recommended Dividend Re 0.25 paise per equity share of face value of Re 1/- each (25%) for the financial year ended March 31, 2009, subject to the approval of Members in ensuing Annual General Meeting. Further the Dr. Martin Tolar has joined the Board of Directors as Additional Director W.e.f. July 28, 2009. Further the Brief Financial as required to be furnished under clause 20 shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
25 Jul · Dividend
Board of Directors in its meeting held on July 25, 2008 has recommended Dividend @ 25% of face value of Re 1/- each (Re 0.25 paise per share) for the financial year ended March 31, 2008, subject to the approval of Members in ensuing Annual General Meeting.
Jul 2007
31 Jul · Dividend
Board at its meeting held on July 31, 2007 has recommended a dividend of Rs. 0.25 per share (25%) on the face value of Rs.1 each for the year 06-07.